GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PharmX Technologies Ltd (ASX:PHX) » Definitions » Days Sales Outstanding

PharmX Technologies (ASX:PHX) Days Sales Outstanding : 47.65 (As of Dec. 2024)


View and export this data going back to 1973. Start your Free Trial

What is PharmX Technologies Days Sales Outstanding?

PharmX Technologies's average Accounts Receivable for the six months ended in Dec. 2024 was A$0.95 Mil. PharmX Technologies's Revenue for the six months ended in Dec. 2024 was A$3.66 Mil. Hence, PharmX Technologies's Days Sales Outstanding for the six months ended in Dec. 2024 was 47.65.

The historical rank and industry rank for PharmX Technologies's Days Sales Outstanding or its related term are showing as below:

ASX:PHX' s Days Sales Outstanding Range Over the Past 10 Years
Min: 9.05   Med: 19.87   Max: 79.89
Current: 79.89

During the past 13 years, PharmX Technologies's highest Days Sales Outstanding was 79.89. The lowest was 9.05. And the median was 19.87.

ASX:PHX's Days Sales Outstanding is ranked worse than
76.59% of 662 companies
in the Healthcare Providers & Services industry
Industry Median: 48.18 vs ASX:PHX: 79.89

PharmX Technologies's Days Sales Outstanding declined from Dec. 2023 (104.64) to Dec. 2024 (47.65).


PharmX Technologies Days Sales Outstanding Historical Data

The historical data trend for PharmX Technologies's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmX Technologies Days Sales Outstanding Chart

PharmX Technologies Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.29 - 30.45 60.68 53.79

PharmX Technologies Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.80 - 104.64 100.53 47.65

Competitive Comparison of PharmX Technologies's Days Sales Outstanding

For the Health Information Services subindustry, PharmX Technologies's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmX Technologies's Days Sales Outstanding Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PharmX Technologies's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where PharmX Technologies's Days Sales Outstanding falls into.


;
;

PharmX Technologies Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

PharmX Technologies's Days Sales Outstanding for the fiscal year that ended in Jun. 2024 is calculated as

Days Sales Outstanding (A: Jun. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2023 ) + Accounts Receivable (A: Jun. 2024 )) / count ) / Revenue (A: Jun. 2024 )*Days in Period
=( (0.915 + 0.997) / 2 ) / 6.487*365
=0.956 / 6.487*365
=53.79

PharmX Technologies's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

Days Sales Outstanding (Q: Dec. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2024 ) + Accounts Receivable (A: Dec. 2024 )) / count ) / Revenue (A: Dec. 2024 )*Days in Period
=( (0.997 + 0.912) / 2 ) / 3.656*365 / 2
=0.9545 / 3.656*365 / 2
=47.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PharmX Technologies  (ASX:PHX) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


PharmX Technologies Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of PharmX Technologies's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmX Technologies Business Description

Traded in Other Exchanges
N/A
Address
17 Castlereagh Street, Suite 11.02, Level 11, Sydney, NSW, AUS, 2000
PharmX Technologies Ltd is an Australia-based software and technology company. The company has a single segment which is Health Services. In Health services, the company develops and distributes business software for the pharmacy industry with particular emphasis on point-of-sale and pharmaceutical dispensing software, support services, and associated computer hardware. It derives a majority of its revenue from the Health services business.